Schedule 21 [LS17] Treatment strategy when we MET NSCLC patients with METex14 skiping mutation―with my clinical experience― ○Stephen V. Liu (Thoracic Oncology, Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC)
